Filter by content type
Filter by year
Vaccinex Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, to Evaluate the Combination of VX15/2503, and Avelumab in Non-Small Cell Lung Cancer
October 6, 2016 - … Combination of VX15/2503, and Avelumab in Non-Small Cell Lung Cancer … Vaccinex Announces Clinical Collaboration with … Combination of VX15/2503, and Avelumab in Non-Small Cell Lung Cancer Vaccinex Announces Clinical Collaboration with … Combination of VX15/2503, and Avelumab in Non-Small Cell Lung Cancer 10/06/16 General Rochester, New York, October 6, …
Vaccinex Featured in a Press Release from the Society for Immunotherapy of Cancer (SITC)
December 5, 2016 - … or anti-CTLA-4 for the treatment of non-small cell lung cancer (NSCLC), melanoma, and head and neck squamous … or anti-CTLA-4 for the treatment of non-small cell lung cancer (NSCLC), melanoma, and head and neck squamous … or anti-CTLA-4 for the treatment of non-small cell lung cancer (NSCLC), melanoma, and head and neck squamous …